Share this @internewscast.com

WASHINGTON — The Supreme Court on Wednesday took up a high-stakes legal battle that could lead to a definitive decision on whether the drug most commonly used for medication abortions will continue to be easily available, including by mail.

The court agreed to weigh appeals from the Biden administration and drugmaker Danco defending several Food and Drug Administration decisions that made it easier to access and use the mifepristone pill. Danco makes the brand version of the pill, Mifeprex.

The justices will hear oral arguments early next year, with a ruling due by the end of June.

The Biden administration welcomed the court’s intervention, with White House Press Secretary Karine Jean-Pierre saying in a statement that the lower court ruling under review “threatens to undermine the FDA’s scientific independent judgment and would reimpose outdated restrictions on access to safe and effective abortion medication.”

Danco said in a statement that it remains confident in the “safety and effectiveness” of the Mifeprex, which will stay available as normal under the current FDA rules while the Supreme Court hears the case.

“The FDA actions at issue were well supported by extensive safety and effectiveness data from clinical trials and decades worth of real-world experience in millions of patients,” the company’s statement added.

The legal challenge was brought by doctors and other medical professionals represented by the conservative Christian legal group Alliance Defending Freedom.

“Every court so far has agreed that the FDA acted unlawfully in removing common-sense safeguards for women and authorizing dangerous mail-order abortions,” said Erin Hawley, one of the group’s lawyers. “We urge the Supreme Court to do the same.”

The court, which has a 6-3 conservative majority, has previously shown hostility to abortion rights, overturning the landmark abortion rights ruling Roe v. Wade last year. But in April, in an earlier stage of the litigation, the court blocked a judge’s ruling that would have completely invalidated the FDA’s approval of the drug.

The abortion pill dispute does not directly address any right to abortion, focusing instead on different legal issues about the FDA’s process for approving drugs, but the case raised questions over the court’s pledge last year to leave abortion policy to the states and the federal government.

The FDA’s original decision in 2000 to approve the drug is not at issue in the Supreme Court, with the court turning away a separate appeal raising that issue.

The court will instead focus on later FDA actions from 2016 onward that made it easier to access the pill, including the initial 2021 decision that made it available by mail, which was finalized earlier this year.

Also under review are the 2016 decisions to extend the window in which mifepristone could be used to terminate pregnancies from seven weeks’ gestation to 10 weeks and reduce the number of in-person visits for patients from three to one. In another 2016 move, the FDA altered the dosing regimen, finding that a lower dose of mifepristone was sufficient.

Another way the court could dispose of the case would be to conclude that the challengers do not have legal standing to bring their lawsuit.

In 2019, the FDA approved a generic form of the drug, which is made by GenBioPro, although that issue is not at issue at the Supreme Court.

The New Orleans-based 5th U.S. Circuit Court of Appeals in August ruled that the post-2016 FDA decisions should be put on hold because the moves “were taken without sufficient consideration of the effects those changes would have on patients.” The court ruled against the challengers on their efforts to overturn the original approval of the drug and the later decision to authorize the generic version.

Both sides then filed appeals at the Supreme Court.

The current fight over the drug dates to a November 2022 lawsuit filed by the challengers. They claim that the FDA’s 2000 approval was flawed, as were later decisions that made the drug easier to access, in part because they failed to take into account safety risks to women. 

In a sweeping decision, Texas-based U.S. District Judge Matthew Kacsmaryk in April invalidated the FDA’s original approval of the drug from more than 20 years ago. After the Supreme Court put that decision on hold while litigation continued, the appeals court narrowed the scope of Kacsmaryk’s ruling, focusing on the post-2016 changes.

The FDA-approved regimen for a medication abortion involves two drugs: mifepristone, which blocks the hormone progesterone, and misoprostol, which induces contractions. A majority of abortions in the U.S. are carried out using the pills, according to a survey conducted by the Guttmacher Institute, a research group that supports abortion rights.

Access to medication abortion, especially by mail, has become of major importance in light of the Supreme Court ruling that overturned Roe v. Wade, which has led to conservative states enacting tough restrictions that either limit or ban abortion outright. Fourteen states currently have total abortion bans, according to Guttmacher.

Share this @internewscast.com
You May Also Like
Antisemitic attackers violently target synagogue, Israeli restaurant in Australia

Attackers with antisemitic intent violently target synagogue and Israeli restaurant in Australia

<!–> Rise in Antisemitic Incidents in Australia A synagogue in Melbourne was…
UN commission accuses Israel of 'extermination' in controversial report

UN Criticized for Funding Committee Aiming to Undermine Israel, Despite Financial Shortfall

Critics have expressed outrage at the United Nations for allocating funds to…
American veterans attacked, injured while distributing aid in Gaza with US-backed group

US-backed group distributing aid in Gaza reports assault and injuries to American veterans

Two American war veterans involved with the U.S.- and Israeli-supported Gaza Humanitarian…
Delicious: NPR Quietly Forced to Report Major Restaurant Chain Is Ending Egg Surcharge for Customers

Tasty Tidbit: NPR Subtly Reveals Major Restaurant Chain’s Decision to Remove Egg Surcharge

Since President Trump assumed office, the price of eggs has significantly decreased,…
Collapsed gangway knocks out power at Fernandina Harbor Marina

Power Outage at Fernandina Harbor Marina Due to Gangway Collapse

The gangway collapsed Friday night during a fireworks show, plunging spectators into…
Subway riders deliver street justice to brute who grabbed screaming woman on platform

Subway Commuters Take Action Against Man Who Attacked Woman on Platform

A group of everyday New York City subway riders delivered some street…
Christie Brinkley admits she is a 'fool for love' despite four failed marriages

Christie Brinkley Confesses She’s a ‘Romantic at Heart’ Even After Four Divorces

Christie Brinkley is no stranger to love. The legendary supermodel, who has been…
Brooks Nader's period stain steals the spotlight during wardrobe mishap at Wimbledon

Brooks Nader’s Wardrobe Blunder at Wimbledon: Period Stain Catches Attention

Brooks Nader poked fun at herself after unexpectedly getting her period during…
Tucker Carlson set to release interview with Iranian president

Tucker Carlson prepares to unveil an interview with the Iranian president

Tucker Carlson is preparing to unveil an interview with Iran’s president, posing…
Houston-born Heart O' the Hills camp director dies in Kerr County floods

Director of Heart O’ the Hills Camp, a Native Houstonian, Passes Away in Kerr County Flooding

“We are mourning the loss of a woman who influenced countless lives…
Parents desperately seeking answers on missing campers after Texas flood

Parents Frantically Seek Information on Campers Missing After Texas Flood

Parents are searching for information about their children’s whereabouts as dozens remain…
Tropical Storm Chantal forms off South Carolina coast

Tropical Storm Chantal Develops Near the Coast of South Carolina

On Saturday morning, Tropical Storm Chantal emerged near the coast of South…